Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level
Abstract Currently, no frontline treatment is effective for the late-stage colorectal cancer (CRC). Understanding the molecular differences in different stages of CRC can help us to identify the critical therapeutic targets for designing therapeutic strategy. Our data show that c-Myc protein is high...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/48a7c6e3af874158bb18f8448c34d87e |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|